J-Pharma Co.,Ltd.
Status: Publicly traded
Last reviewed: November 2026
Direct answer
J-Pharma Co.,Ltd. is publicly traded on JPX under the ticker 520A.T.
J-Pharma Co., Ltd. is engaged in drug discovery and development, focusing on amino acid transporters as drug targets. The company researches and develops drugs targeting solute carrier (SLC) transporters, with emphasis on the LAT1 amino acid transporter. It is developing several compounds for various medical indications, including JPH034 for central nervous system demyelinating diseases and multiple sclerosis. The...
Can you invest in J-Pharma Co.,Ltd.?
Yes. J-Pharma Co.,Ltd. is publicly traded on JPX under the ticker 520A.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for J-Pharma Co.,Ltd.
Detailed equity research is provided by MarketSnap.